APA (7th ed.) Citation

A, A., JL, G., A, S., C, B., M, F., E, C., . . . X, S. (2025). Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients. Clinical immunology (Orlando, Fla.), 276, 110491. https://doi.org/10.1016/j.clim.2025.110491

Chicago Style (17th ed.) Citation

A, Antolí, et al. "Autoantibodies Neutralizing Type I Interferons Remain a Significant Risk Factor for Critical COVID-19 Pneumonia in Vaccinated Patients." Clinical Immunology (Orlando, Fla.) 276 (2025): 110491. https://doi.org/10.1016/j.clim.2025.110491.

MLA (9th ed.) Citation

A, Antolí, et al. "Autoantibodies Neutralizing Type I Interferons Remain a Significant Risk Factor for Critical COVID-19 Pneumonia in Vaccinated Patients." Clinical Immunology (Orlando, Fla.), vol. 276, 2025, p. 110491, https://doi.org/10.1016/j.clim.2025.110491.